Leweke, F. M., Rohleder, C., Gerth, C. W., Hellmich, M., Pukrop, R., & Köthe, D. (2021). Cannabidiol and amisulpride improve cognition in acute schizophrenia in an explorative, double-blind, active-controlled, randomized clinical trial. Frontiers in pharmacology, 12, . https://doi.org/10.3389/fphar.2021.614811
Chicago-Zitierstil (17. Ausg.)Leweke, F. Markus, Cathrin Rohleder, Christoph W. Gerth, Martin Hellmich, Ralf Pukrop, und Dagmar Köthe. "Cannabidiol and Amisulpride Improve Cognition in Acute Schizophrenia in an Explorative, Double-blind, Active-controlled, Randomized Clinical Trial." Frontiers in Pharmacology 12 (2021). https://doi.org/10.3389/fphar.2021.614811.
MLA-Zitierstil (9. Ausg.)Leweke, F. Markus, et al. "Cannabidiol and Amisulpride Improve Cognition in Acute Schizophrenia in an Explorative, Double-blind, Active-controlled, Randomized Clinical Trial." Frontiers in Pharmacology, vol. 12, 2021, https://doi.org/10.3389/fphar.2021.614811.